【摘 要】
:
6-Gingerol,a pungent ingredient of ginger,has been reported to possess anti-inflammatory and antioxidant activities,but the effect of 6-gingerol on pressure overload-induced cardiac remodeling remains inconclusive.In this study,we investigated the effect
【机 构】
:
Department of Cardiology,Renmin Hospital of Wuhan University,Wuhan 430060,China;Cardiovascular Resea
论文部分内容阅读
6-Gingerol,a pungent ingredient of ginger,has been reported to possess anti-inflammatory and antioxidant activities,but the effect of 6-gingerol on pressure overload-induced cardiac remodeling remains inconclusive.In this study,we investigated the effect of 6-gingerol on cardiac remodeling in in vivo and in vitro models,and to clarify the underlying mechanisms.C57BL/6 mice were subjected to transverse aortic constriction (TAC),and treated with 6-gingerol (20 mg/kg,ig) three times a week(1 week in advance and continued until the end of the experiment).Four weeks after TAC surgery,the mice were subjected to echocardiography,and then sacrificed to harvest the hearts for analysis.For in vitro study,neonatal rat cardiomyocytes and cardiac fibroblasts were used to validate the protective effects of 6-gingerol in response to phenylephrine (PE) and transforming growth factor-β (TGF-β) challenge.We showed that 6-gingerol administration protected against pressure overload-induced cardiac hypertrophy,fibrosis,inflammation,and dysfunction in TAC mice.In the in vitro study,we showed that treatment with 6-gingerol (20 μM) blocked PE-induced-cardiomyocyte hypertrophy and TGF-β-induced cardiac fibroblast activation.Furthermore,6-gingerol treatment significantly decreased mitogen-activated protein kinase p38 (p38) phosphorylation in response to pressure overload in vivo and extracellular stimuli in vitro,which was upregulated in the absence of 6-gingerol treatment.Moreover,transfection with mitogen-activated protein kinase kinase 6 expressing adenoviruses (Ad-MKK6),which specifically activated p38,abolished the protective effects of 6-gingerol in both in vitro and in vivo models.In conclusion,6-gingerol improves cardiac function and alleviates cardiac remodeling induced by pressure overload in a p38-dependent manner.The present study demonstrates that 6-gingerol is a promising agent for the intervention of pathological cardiac remodeling.
其他文献
目的:基于Taqman探针结合熔解曲线技术,建立1种简单、高效的快速检测抗高血压药物相关基因多态位点的基因分型方法,指导临床上抗高血压药物的个性化给药方式,从而有效降低不良反应发生率.方法:随机采集200例原发性高血压患者的口腔粘膜脱落细胞,通过提取口腔粘膜脱落细胞基因组DNA,设计特异性的Taqman探针和不对称扩增引物,在2个反应管中采用多色Taqman探针结合熔解曲线技术对提取的基因组DNA的5个抗高血压药物相关基因多态位点进行基因分型检测,并随机抽取不同基因型的样本进行基因测序验证.结果:Taqm
目的:建立激光衍射法测定盐酸溴己新原料药的粒度及分布,探讨原料药粒度对药物制剂体外溶出的影响.方法:Malvern Mastersizer 3000激光粒度仪,AERO S干法进样器;背景测量时间10 s,样品测量时间15s;遮光度范围为0.50%~5%;颗粒折射率1.626,吸收率0.1;分析模型为通用的细的干粉模型;样品分散气压为350 kPa;进样速度为40%;料斗间隙为2.0 mm;样品量为200 mg.结果:激光衍射法可准确测定盐酸溴已新原料药粒度分布,方法精密度和样品测定值RSD均小于5%.4
目的:建立一测多评法同时测定蒙药述达格-4总黄酮提取物中槲皮素、山柰酚、高良姜素、山柰素、高良姜素-3-甲醚5个黄酮类成分的含量.方法:采用Agilent C18色谱柱(250 mm×4.6 mm,5μm),流动相为甲醇(B)-0.5%乙酸水溶液(A),梯度洗脱,流速0.6 mL· min-1,柱温30℃,进样量20 μL,检测波长:286 nm检测山柰酚、山柰素、高良姜素-3-甲醚,256 nm检测槲皮素.以高良姜素为内参,计算其他4个黄酮类成分的相对校正因子,采用该相对校正因子计算其他4个成分的含量,
目的:建立激光散射法湿法测定利伐沙班原料药粒度分布并进行方法学验证.方法:采用Malvem Mastersizer 2000型激光粒度分析仪,Hydro 2000 MU湿法进样器,分散介质为水,聚山梨酯20作为分散剂,超声强度20 MHz,超声50 s,浆液循环泵转速2100 r·min-1,背景与样品扫描时间10 s,测量次数4次.结果:样品折射率1.633,样品吸光率0.1,遮光率8%~15%.方法学考察结果粒度分布值d(0.9)的RSD均小于2%;6批利伐沙班原料药样品粒径分布特征值均符合d(0.9
目的:运用密度泛函理论方法,研究苯并噻唑(benzothiazole,BTA)类药物及其类似物的结构性质和光谱性质.方法:运用密度泛函理论X3LYP/6-311+G(d,p)方法计算分析BTA类药物利鲁唑、依索唑胺、夫仑替唑、唑泊司他以及4种类似物的几何结构和电子结构、紫外-可见吸收光谱、红外振动光谱、拉曼光谱、荧光光谱和振动圆二色谱,采用概念密度泛函理论定量并可视化预测其可能的反应位点.结果:4种药物药效结构相同,利鲁唑和夫仑替唑分子的几何数据计算值与实验值基本吻合,4种类似物(4种最小抑菌浓度化合物,
目的:建立柱前衍生-HPLC法测定氨咖黄敏胶囊中6个效应成分(对乙酰氨基酚、咖啡因、马来酸氯苯那敏、胆红素、胆酸、猪去氧胆酸)及2个杂质成分(对氨基酚和对氯苯乙酰胺)的含量.方法:以2-萘基溴甲基酮为衍生剂,三乙胺为催化剂,以0.02%醋酸溶液(A)-甲醇(B)-乙腈(C)为流动相,以265 nm和446 nm(胆红素)为检测波长,对各成分进行梯度洗脱.结果:对乙酰氨基酚在49.62~620.24μg·mL-1浓度范围内线性良好(r=0.9990),咖啡因在3.29~41.10μg·mL-1浓度范围内线性
目的:建立HPLC法测定不同来源复方甘草酸苷注射液中甘氨酸与盐酸半胱氨酸的含量,并对易降解氨基酸的稳定性进行考察、评价.方法:采用Agilent Eclipse XDB-C18色谱柱(4.6 mm×150 mm,5μm),流动相为甲醇--0.01 mol·L-1磷酸盐缓冲液(磷酸调pH 2.15±0.02)(5∶95),检测波长为210 nm.结果:不同生产企业的复方甘草酸苷注射液中,甘氨酸含量为99.1%~101.7%;原研制剂的盐酸半胱氨酸平均含量是103.9%,未检出胱氨酸,其他样品中盐酸半胱氨酸含
目的:研究华法林钠的生物药剂学特征,利用计算机模拟技术研究药物体外溶出与体内吸收的相关性,比较研究华法林钠片仿制制剂与参比制剂(reference listed drug,RLD)的溶出行为.方法:通过测定华法林钠在不同pH介质中的溶解性与平行人工膜渗透性模型(the parallel artificial membrane permeability assay,PAMPA)渗透性,分析研究了药物的生物药剂学特征;绘制药物制剂在多种介质中的溶出曲线,比较研究华法林钠片仿制药与RLD的溶出行为一致性;基于R
Fingolimod has beneficial effects on multiple diseases,including type 1 diabetes (T1D) and numerous preclinical models of colitis.Intestinal dysbiosis and intestinal immune dysfunction contribute to disease pathogenesis of T1D.Thus,the beneficial effect o
Septic acute liver injury is one of the leading causes of fatalities in patients with sepsis.Toll-like receptor 4 (TLR4) plays a vital role in response to lipopolysaccharide (LPS) challenge,but the mechanisms underlying TLR4 function in septic injury rema